LITS - MEI Pharma, Inc.
1.18
0 0%
Share volume: 397,835
Last Updated: 04-24-2026
Pharmaceutical Products/Pharmaceutical Preparations:
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$1.18
0.00
0.00%
View ratios
| Fiscal Date | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 11-09-2023 | 02-13-2024 | 05-09-2024 | 11-12-2024 | 11-12-2024 | 02-12-2025 | 05-13-2025 | 09-26-2025 | |
| Total revenue | 65.297 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 65.297 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| -100.00% | nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 10.016 M | 11.930 M | 9.829 M | 8.081 M | 8.352 M | 3.451 M | 2.774 M | 2.878 M | |
| Selling general and admin | 6.531 M | 8.018 M | 4.609 M | 4.137 M | 5.189 M | 3.143 M | 2.405 M | 2.795 M | |
| Research and development | 3.485 M | 3.912 M | 5.220 M | 3.944 M | 3.163 M | 308.000 K | 369.000 K | 83.000 K | |
| Total expenses | 10.016 M | 11.930 M | 9.829 M | 18.980 M | 8.352 M | 3.451 M | 2.774 M | 2.878 M | |
| 19.11% | -17.61% | 93.10% | -56.00% | -58.68% | -19.62% | 3.75% | |||
| Operating income | 55.281 M | -11.930 M | -9.829 M | -18.980 M | -8.352 M | -3.451 M | -2.774 M | -2.878 M | |
| Ebit | 55.281 M | -11.932 M | -9.829 M | -18.980 M | -8.362 M | -2.956 M | -2.774 M | -2.878 M | |
| Pretax income | 56.374 M | -11.063 M | -9.127 M | -18.365 M | -8.007 M | -2.677 M | -2.573 M | -2.688 M | |
| -119.62% | -17.50% | 101.22% | -56.40% | -66.57% | -3.88% | 4.47% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 56.374 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| -100.00% | |||||||||
| Net income | 56.374 M | -11.063 M | -9.127 M | -18.406 M | -8.007 M | -2.677 M | -2.573 M | -2.688 M | |
| -119.62% | 17.50% | -101.67% | 56.50% | 66.57% | 3.88% | -4.47% |